| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |